Welcome to the IMPACT Academy

An educational initiative developed for healthcare professionals aim to improve outcomes for patients with cardiovascular, renal and metabolic diseases.The education programs are endorsed by an expert steering committee of practising clinicians in specialities across the disease spectrum.

Dive in to see the programs we have on offer

Welcome to the IMPACT Academy

Dive in to see the programs we have on offer

Featured
LATEST

Recommended Content

COVID-19 and its implications in heart failure
PRESENTATION
COVID-19 and its implications in heart failure
View Content
Can new-onset diabetes be prevented by dapagliflozin? Insights from DAPA-HF
PRESENTATION
Can new-onset diabetes be prevented by dapagliflozin? Insights from DAPA-HF
View Content
Practicalities of SGLT2 inhibition – pros vs cons
INFOGRAPHIC
Practicalities of SGLT2 inhibition – pros vs cons
View Content
Updates on ESC heart failure guidelines
VIDEO
Updates on ESC heart failure guidelines
View Content
Dapagliflozin: Cardiologist Practical Guide to Prescribing Dapagliflozin
INFOGRAPHIC
Dapagliflozin: Cardiologist Practical Guide to Prescribing Dapagliflozin
View Content
Featured
LATEST

Trending Content

The story of heart failure prevention with SGLT2 inhibitors in diabetes: Key learnings for cardiologist
PRESENTATION
The story of heart failure prevention with SGLT2 inhibitors in diabetes: Key learnings for cardiologist
View Content
Dapagliflozin: Cardiologist Practical Guide to Prescribing Dapagliflozin
INFOGRAPHIC
Dapagliflozin: Cardiologist Practical Guide to Prescribing Dapagliflozin
View Content
Safety and tolerability of SGLT2 inhibitors – how and when should I initiate treatment
VIDEO
Safety and tolerability of SGLT2 inhibitors – how and when should I initiate treatment
View Content
Cardiorenal benefits of SGLT2 inhibitors
PRESENTATION
Cardiorenal benefits of SGLT2 inhibitors
View Content
Diagnosis and co-morbidities of chronic kidney disease
VIDEO
Diagnosis and co-morbidities of chronic kidney disease
View Content